The American Society of Clinical Oncology (ASCO) today released a position statement on state drug repository programs, outlining ASCO’s support for drug repository programs solely for oral ...

All Conquer Cancer research grant applications are carefully reviewed and evaluated by an independent Grants Selection Committee (Committee) using consistent criteria across all applications for each ...

The FASCO designation honors members for their extraordinary volunteer service, engagement, and dedication to the American Society of Clinical Oncology and the Association for Clinical Oncology ...

ASCO® Guidelines Assistant is an interactive AI tool developed by ASCO and Google Cloud. The tool allows oncologists to quickly search and use ASCO Guidelines through a simple, intuitive chat. Quickly ...

This section provides key information on oncology events organized by ASCO or other organizations throughout the world. To submit an event, please fill out this form. Content on ASCO's Calendar of ...

To learn more about the ASCO guideline development process, access the full ASCO Guideline Methodology Manual. ASCO Clinical Practice Guidelines are evidence-based products based on a systematic ...

The American Society of Clinical Oncology (ASCO) is a professional oncology society committed to conquering cancer through research, education, prevention, and the delivery of high-quality patient ...

ASCO provides numerous quality activities aimed at improving the standard of cancer care received by patients in the United States and around the world. ASCO Certified is a program that certifies ...

Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.

Quality Oncology Practice Initiative (QOPI®) Certified Practices can routinely evaluate practice performance against quality measures and standards established by experts in the oncology field.

Thank you for your interest in the ASCO Plenary Series. Effective June 2024, the Series will pause indefinitely and is not accepting abstract submissions. With greatly increased demand for in-person ...